Definitive Contract 75A50124C00001
Award Date
12/15/23
Potential Completion Date
9/30/30
Potential Value
$222M
Awardee
PPD Development LP
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Incentive
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization (CRO). The contract, valued at $64,031,927.00, is for completing the ACTIV 2 study to support COVID-19 research. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher...
This firm-fixed-price purchase order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to PPD Development LP, a global contract research organization (CRO), to establish a high-throughput severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binding antibody immunoassay capability and test human serum samples. The $11,503,402.18 contract has a period of performance through November 22, 2021 and does not utilize a set-aside....
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is...
This is a $16,382,387.80 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to PPD Development, LP. The contract is for clinical services described in Tasks 1 through 15 under the ASPR-16-05933 requirement, which is part of the Medical Countermeasures Clinical Studies Network IDIQ contract vehicle. The contract is for a Heterologous Prime Boost Influenza Vaccine Trial and does not have a set-aside...
This is a $1,299,218 definitive contract awarded by the Food and Drug Administration (FDA) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for "BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS" and has a completion date of February 2, 2026. The contract is a Time and Materials type with no set-aside designation. As a CRO, PPD...
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The $18,792,842.54 contract is for the Immune Tolerance Network - Clinical Site Monitoring Group, which involves comprehensive clinical trial and research support services such as regulatory affairs, clinical site...
This is a delivery order under the Medical Countermeasures Clinical Studies Network contract vehicle, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development, LP, a global contract research organization (CRO). The $6,186,155.39 delivery order is for a H5N1 clinical study, under a cost-plus-fixed-fee contract type. PPD Development, LP has been awarded over $500 million in prime federal contracts and participated as a subcontractor on grants and...
This is a cost-plus-award-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, titled "NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)", has a ceiling value of $342,278,815.66 and a period of performance ending on August 15, 2024.
The contract was awarded...
This is a Delivery Order under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) awarded by the Defense Health Agency (DHA) to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The $516,110.95 cost-plus-fixed-fee contract supports an HIV Cohort Study, with a period of performance through October 13, 2022. The contract does not have a set-aside designation. PPD Development LP, a highly experienced federal...
This is a delivery order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The $305,319.33 cost-plus-fixed-fee contract is for R&D services related to burn treatment healthcare cost analysis. It is a task order under the broader Medical Product Research and Development indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. PPD Development LP...